Medicine and Dentistry
Peritonsillar Abscess
100%
Tonsillitis
97%
Tonsillectomy
91%
Prevalence
57%
Fusobacterium necrophorum
45%
Infection
44%
Pathogen
39%
Cancer
31%
Retrospective Study
30%
Neck
29%
Quality of Life
27%
Recurrent Disease
26%
Tonsil
26%
Sore Throat
25%
Prognostic Factor
24%
Antibiotics
23%
Salivary Gland Carcinoma
22%
Bleeding
20%
Parotid Gland
20%
Survival Rate
20%
Symptom
19%
Streptococcus Group A
19%
Retropharyngeal Abscess
19%
Systematic Review
19%
Sarcoma
19%
Positron Emission Tomography-Computed Tomography
19%
Tonsil Cancer
19%
Neck Dissection
19%
Antibiotic Therapy
18%
Hazard Ratio
15%
Patient-Reported Outcome
15%
Surgery
15%
General Medicine
15%
Head and Neck Cancer
14%
Streptococcus pyogenes
14%
Staphylococcus Aureus
14%
Otorhinolaryngology
13%
Multivariate Analysis
13%
Cohort Effect
13%
Incision
13%
Clinical Trial
12%
Neoplasm
12%
Salivary Gland
12%
Cohort Analysis
12%
Submandibular Gland
11%
Recurrence Free Survival
11%
Penicillin Derivative
11%
Diagnosis
11%
Palatine Tonsil
11%
Randomized Controlled Trial
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
55%
Peritonsillar Abscess
54%
Antibiotics
43%
Tonsillitis
38%
Fusobacterium necrophorum
32%
Antibiotic Agent
27%
Prevalence
24%
Staphylococcus Aureus
23%
Retropharyngeal Abscess
23%
Ear Infection
22%
Nose Infection
22%
Pharyngitis
22%
Abscess
22%
Clinical Trial
21%
Penicillin Derivative
18%
Infectious Agent
18%
Recurrent Disease
15%
Head and Neck Cancer
14%
Metronidazole
11%
Mixed Infection
9%
Toxic Shock Syndrome
9%
Parotid Gland Carcinoma
9%
Observational Study
9%
Lymphadenitis
9%
Fluorodeoxyglucose F 18
9%
Acute Epiglottitis
9%
Mononucleosis
9%
Melanoma
9%
Adenoid Cystic Carcinoma
9%
Carcinoma
9%
Survival Rate
9%
Incidentaloma
9%
Pseudomonas aeruginosa
8%
Antibiotic Therapy
8%
Streptococcus Group A
7%
Cefuroxime
6%
C Reactive Protein
6%
Streptococcus
5%
Immunology and Microbiology
Tonsillitis
76%
Abscess
62%
Fusobacterium necrophorum
56%
Infectious Agent
55%
Microbiology
48%
Nose
32%
Streptococcus pyogenes
28%
Pharyngitis
24%
Prevalence
22%
Staphylococcus Aureus
14%
Tonsil
14%
Streptococcus anginosus
13%
Neck
13%
Prevotella
12%
Middle Ear
11%
Coinfection
9%
Hib Vaccine
9%
Perichondritis
9%
Auricle
9%
Mononucleosis
9%
Phlegmon
9%
Lymph Node
9%
Next Generation Sequencing
9%
Microbiome
9%
Streptococcus Group A
6%
Oropharynx
5%
Anaerobe
5%
